Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Metalsguy1on Apr 02, 2021 7:01pm
154 Views
Post# 32932869

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr. Toleikis deserves our Respect and Vote

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr. Toleikis deserves our Respect and Vote
Rose. Step away from the flowers and you can smell the rot and corruption in this deal. How could anyone have said yes to it.. The momentum on the back of stellar news was off the charts. Sure, no stock goes straight up but the momentum should have carried into strong consolidation and a rising trend line. Instead we have Dougy coming out with a 12 month price target of 2.50 on January 19th just 3 or 4 days after we had already broken well past that with one intraday over $3 At the same time Leede and Canaccord were negotiating a bought deal. How do you make sure you get sweet deal? Tell the world you don't think the stock will be worth 2.50 for another 12 months and then short the heck out of it. It should be illegal if not at least unethical for Leede to issue a price target when negotiating a bought deal. Phil should have told them to get stuffed on the trading action alone.
<< Previous
Bullboard Posts
Next >>